Equities
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Profile data is unavailable for this security.

About the company

Johnson & Johnson is a holding company that is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates through three segments: Consumer Health, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer Health segment includes a range of products that is focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women’s health and wound care markets. The Pharmaceutical segment is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension. The Medical Devices segment includes a range of products used in the interventional solutions, orthopaedics, surgery, and vision fields. Its geographic area includes the United States, Europe, Western Hemisphere (excluding the United States), and Africa, Asia and Pacific.

  • Revenue in USD (TTM)95.59bn
  • Net income in USD18.37bn
  • Incorporated1887
  • Employees141.70k
  • Location
    Johnson & JohnsonOne Johnson & Johnson PlazaNEW BRUNSWICK 08933United StatesUSA
  • Phone+1 (732) 524-2455
  • Fax+1 (732) 214-0332
  • Websitehttps://www.jnj.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Amgen, Inc.26.38bn6.58bn132.86bn24.20k21.3655.7413.565.1111.8011.8047.504.520.44321.485.381,090,248.0011.0511.0714.3213.4075.7579.2924.9230.881.177.460.937949.282.182.47-18.87-5.261.0111.97
Bristol-Myers Squibb Co47.14bn6.62bn160.06bn32.20k24.884.909.343.393.013.0121.4915.270.44654.586.001,464,099.006.292.677.763.2979.2274.1814.086.541.345.550.5629163.849.0919.01177.589.43-4.355.22
Merck & Co., Inc.57.17bn16.64bn226.78bn68.00k13.605.2211.133.956.566.5322.5317.070.57813.036.54840,720.6016.847.6121.8310.1470.7770.9229.1316.061.1521.890.422386.0617.314.12173.1825.7922.487.49
AbbVie Inc57.35bn12.57bn247.98bn50.00k19.9317.0111.924.357.077.0732.278.290.39394.955.421,146,980.008.697.4611.109.4670.7272.0322.0518.110.74568.270.832497.8922.6916.99151.7114.1310.4417.93
Pfizer Inc.101.13bn29.75bn279.31bn79.00k9.63--8.142.775.195.1117.62--------1,280,152.00--6.62--8.2562.2174.0429.4421.32--22.12--75.7295.169.00238.0525.516.285.39
Eli Lilly And Co29.07bn5.69bn287.92bn35.00k48.6133.8739.639.966.276.2732.028.990.61281.814.77830,591.4012.0011.0817.8315.8075.9877.1619.5820.770.8467.330.660153.7515.405.94-9.8815.3111.4010.76
Johnson & Johnson95.59bn18.37bn447.43bn141.70k24.815.8817.574.696.886.8835.8029.040.53982.856.16674,580.1010.379.9513.5712.7367.8966.8719.2119.211.17123.700.299262.3313.555.4644.854.772.515.87
Data as of Aug 12 2022. Currency figures normalised to Johnson & Johnson's reporting currency: US Dollar USD

Institutional shareholders

27.25%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Mar 2022227.92m8.66%
SSgA Funds Management, Inc.as of 31 Mar 2022142.23m5.41%
BlackRock Fund Advisorsas of 31 Mar 2022126.92m4.82%
Geode Capital Management LLCas of 31 Mar 202245.02m1.71%
Northern Trust Investments, Inc.(Investment Management)as of 31 Mar 202234.05m1.29%
Wellington Management Co. LLPas of 31 Mar 202232.77m1.25%
State Farm Investment Management Corp.as of 31 Mar 202231.68m1.20%
Massachusetts Financial Services Co.as of 31 Mar 202226.56m1.01%
BlackRock Investment Management (UK) Ltd.as of 31 Mar 202225.65m0.98%
Norges Bank Investment Managementas of 31 Dec 202124.39m0.93%
More ▼
Data from 31 Dec 2021 - 31 Mar 2022Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.